Selected research
Market Outlook & Growth Opportunities
Global Glutathione Sepharose 4B Market Outlook and Growth Opportunities 2026
Market perspective
The global Glutathione Sepharose 4B market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Glutathione Sepharose 4B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Glutathione Sepharose 4B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Glutathione Sepharose 4B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Glutathione Sepharose 4B market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Glutathione Sepharose 4B market include Wuhan Crystarose Biotech Co., Ltd., Shanghai Yuanye Bio‑Tech Co., Ltd., Beijing RuiDaHengHui Science&Technology Development Co., LTD, Bioresn Biotech Co., Ltd., Beijing BioRebo Tech Co., Ltd., ZELLX Biochem, Thermo Fisher Scientific, Takara Bio and Sino Biological, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Glutathione Sepharose 4B market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Glutathione Sepharose 4B and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Glutathione Sepharose 4B sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glutathione Sepharose 4B market size, projected growth trends, production technologies, key applications, and end-use industries.
Glutathione Sepharose 4B Segment by Company
Wuhan Crystarose Biotech Co., Ltd.
Shanghai Yuanye Bio‑Tech Co., Ltd.
Beijing RuiDaHengHui Science&Technology Development Co., LTD
Bioresn Biotech Co., Ltd.
Beijing BioRebo Tech Co., Ltd.
ZELLX Biochem
Thermo Fisher Scientific
Takara Bio
Sino Biological
Separopore®
Merck
MedChemExpress
GenScript
Cytiva
Cube Biotech
Creative BioMart
BioVision
Bio-Rad Laboratories
Abcam
Glutathione Sepharose 4B Segment by Type
Covalent Coupling Type
Physical Adsorption Type
Glutathione Sepharose 4B Segment by Application
Biopharmaceutical Industry
Life Science Research
Others
Glutathione Sepharose 4B Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Glutathione Sepharose 4B status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Glutathione Sepharose 4B market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Glutathione Sepharose 4B significant trends, drivers, influence factors in global and regions.
6. To analyze Glutathione Sepharose 4B competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glutathione Sepharose 4B market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glutathione Sepharose 4B and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glutathione Sepharose 4B.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Glutathione Sepharose 4B market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glutathione Sepharose 4B industry.
Chapter 3: Detailed analysis of Glutathione Sepharose 4B manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Glutathione Sepharose 4B in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Glutathione Sepharose 4B in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Covalent Coupling Type
- Physical Adsorption Type
Applications
- Biopharmaceutical Industry
- Life Science Research
- Others
Companies covered
- Wuhan Crystarose Biotech Co., Ltd.
- Shanghai Yuanye Bio‑Tech Co., Ltd.
- Beijing RuiDaHengHui Science&Technology Development Co., LTD
- Bioresn Biotech Co., Ltd.
- Beijing BioRebo Tech Co., Ltd.
- ZELLX Biochem
- Thermo Fisher Scientific
- Takara Bio
- Sino Biological
- Separopore®
- Merck
- MedChemExpress
- GenScript
- Cytiva
- Cube Biotech
- Creative BioMart
- BioVision
- Bio-Rad Laboratories
- Abcam
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Glutathione Sepharose 4B Sales Value (2021-2032)
- 1.2.2 Global Glutathione Sepharose 4B Sales Volume (2021-2032)
- 1.2.3 Global Glutathione Sepharose 4B Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Glutathione Sepharose 4B Market Dynamics
- 2.1 Glutathione Sepharose 4B Industry Trends
- 2.2 Glutathione Sepharose 4B Industry Drivers
- 2.3 Glutathione Sepharose 4B Industry Opportunities and Challenges
- 2.4 Glutathione Sepharose 4B Industry Restraints
3 Glutathione Sepharose 4B Market by Company
- 3.1 Global Glutathione Sepharose 4B Company Revenue Ranking in 2025
- 3.2 Global Glutathione Sepharose 4B Revenue by Company (2021-2026)
- 3.3 Global Glutathione Sepharose 4B Sales Volume by Company (2021-2026)
- 3.4 Global Glutathione Sepharose 4B Average Price by Company (2021-2026)
- 3.5 Global Glutathione Sepharose 4B Company Ranking (2024-2026)
- 3.6 Global Glutathione Sepharose 4B Company Manufacturing Base and Headquarters
- 3.7 Global Glutathione Sepharose 4B Company Product Type and Application
- 3.8 Global Glutathione Sepharose 4B Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Glutathione Sepharose 4B Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Glutathione Sepharose 4B Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Glutathione Sepharose 4B Market by Type
- 4.1 Glutathione Sepharose 4B Type Introduction
- 4.1.1 Covalent Coupling Type
- 4.1.2 Physical Adsorption Type
- 4.2 Global Glutathione Sepharose 4B Sales Volume by Type
- 4.2.1 Global Glutathione Sepharose 4B Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Glutathione Sepharose 4B Sales Volume by Type (2021-2032)
- 4.2.3 Global Glutathione Sepharose 4B Sales Volume Share by Type (2021-2032)
- 4.3 Global Glutathione Sepharose 4B Sales Value by Type
- 4.3.1 Global Glutathione Sepharose 4B Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Glutathione Sepharose 4B Sales Value by Type (2021-2032)
- 4.3.3 Global Glutathione Sepharose 4B Sales Value Share by Type (2021-2032)
5 Glutathione Sepharose 4B Market by Application
- 5.1 Glutathione Sepharose 4B Application Introduction
- 5.1.1 Biopharmaceutical Industry
- 5.1.2 Life Science Research
- 5.1.3 Others
- 5.2 Global Glutathione Sepharose 4B Sales Volume by Application
- 5.2.1 Global Glutathione Sepharose 4B Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Glutathione Sepharose 4B Sales Volume by Application (2021-2032)
- 5.2.3 Global Glutathione Sepharose 4B Sales Volume Share by Application (2021-2032)
- 5.3 Global Glutathione Sepharose 4B Sales Value by Application
- 5.3.1 Global Glutathione Sepharose 4B Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Glutathione Sepharose 4B Sales Value by Application (2021-2032)
- 5.3.3 Global Glutathione Sepharose 4B Sales Value Share by Application (2021-2032)
6 Glutathione Sepharose 4B Regional Sales and Value Analysis
- 6.1 Global Glutathione Sepharose 4B Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Glutathione Sepharose 4B Sales by Region (2021-2032)
- 6.2.1 Global Glutathione Sepharose 4B Sales by Region: 2021-2026
- 6.2.2 Global Glutathione Sepharose 4B Sales by Region (2027-2032)
- 6.3 Global Glutathione Sepharose 4B Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Glutathione Sepharose 4B Sales Value by Region (2021-2032)
- 6.4.1 Global Glutathione Sepharose 4B Sales Value by Region: 2021-2026
- 6.4.2 Global Glutathione Sepharose 4B Sales Value by Region (2027-2032)
- 6.5 Global Glutathione Sepharose 4B Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Glutathione Sepharose 4B Sales Value (2021-2032)
- 6.6.2 North America Glutathione Sepharose 4B Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Glutathione Sepharose 4B Sales Value (2021-2032)
- 6.7.2 Europe Glutathione Sepharose 4B Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Glutathione Sepharose 4B Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Glutathione Sepharose 4B Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Glutathione Sepharose 4B Sales Value (2021-2032)
- 6.9.2 South America Glutathione Sepharose 4B Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Glutathione Sepharose 4B Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Glutathione Sepharose 4B Sales Value Share by Country, 2025 VS 2032
7 Glutathione Sepharose 4B Country-level Sales and Value Analysis
- 7.1 Global Glutathione Sepharose 4B Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Glutathione Sepharose 4B Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Glutathione Sepharose 4B Sales by Country (2021-2032)
- 7.3.1 Global Glutathione Sepharose 4B Sales by Country (2021-2026)
- 7.3.2 Global Glutathione Sepharose 4B Sales by Country (2027-2032)
- 7.4 Global Glutathione Sepharose 4B Sales Value by Country (2021-2032)
- 7.4.1 Global Glutathione Sepharose 4B Sales Value by Country (2021-2026)
- 7.4.2 Global Glutathione Sepharose 4B Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.9.2 France Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.16.2 China Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.19.2 India Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Glutathione Sepharose 4B Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Glutathione Sepharose 4B Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Glutathione Sepharose 4B Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Wuhan Crystarose Biotech Co., Ltd.
- 8.1.1 Wuhan Crystarose Biotech Co., Ltd. Company Information
- 8.1.2 Wuhan Crystarose Biotech Co., Ltd. Business Overview
- 8.1.3 Wuhan Crystarose Biotech Co., Ltd. Glutathione Sepharose 4B Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Wuhan Crystarose Biotech Co., Ltd. Glutathione Sepharose 4B Product Portfolio
- 8.1.5 Wuhan Crystarose Biotech Co., Ltd. Recent Developments
- 8.2 Shanghai Yuanye Bio‑Tech Co., Ltd.
- 8.2.1 Shanghai Yuanye Bio‑Tech Co., Ltd. Company Information
- 8.2.2 Shanghai Yuanye Bio‑Tech Co., Ltd. Business Overview
- 8.2.3 Shanghai Yuanye Bio‑Tech Co., Ltd. Glutathione Sepharose 4B Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Shanghai Yuanye Bio‑Tech Co., Ltd. Glutathione Sepharose 4B Product Portfolio
- 8.2.5 Shanghai Yuanye Bio‑Tech Co., Ltd. Recent Developments
- 8.3 Beijing RuiDaHengHui Science&Technology Development Co., LTD
- 8.3.1 Beijing RuiDaHengHui Science&Technology Development Co., LTD Company Information
- 8.3.2 Beijing RuiDaHengHui Science&Technology Development Co., LTD Business Overview
- 8.3.3 Beijing RuiDaHengHui Science&Technology Development Co., LTD Glutathione Sepharose 4B Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Beijing RuiDaHengHui Science&Technology Development Co., LTD Glutathione Sepharose 4B Product Portfolio
- 8.3.5 Beijing RuiDaHengHui Science&Technology Development Co., LTD Recent Developments
- 8.4 Bioresn Biotech Co., Ltd.
- 8.4.1 Bioresn Biotech Co., Ltd. Company Information
- 8.4.2 Bioresn Biotech Co., Ltd. Business Overview
- 8.4.3 Bioresn Biotech Co., Ltd. Glutathione Sepharose 4B Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Bioresn Biotech Co., Ltd. Glutathione Sepharose 4B Product Portfolio
- 8.4.5 Bioresn Biotech Co., Ltd. Recent Developments
- 8.5 Beijing BioRebo Tech Co., Ltd.
- 8.5.1 Beijing BioRebo Tech Co., Ltd. Company Information
- 8.5.2 Beijing BioRebo Tech Co., Ltd. Business Overview
- 8.5.3 Beijing BioRebo Tech Co., Ltd. Glutathione Sepharose 4B Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Beijing BioRebo Tech Co., Ltd. Glutathione Sepharose 4B Product Portfolio
- 8.5.5 Beijing BioRebo Tech Co., Ltd. Recent Developments
- 8.6 ZELLX Biochem
- 8.6.1 ZELLX Biochem Company Information
- 8.6.2 ZELLX Biochem Business Overview
- 8.6.3 ZELLX Biochem Glutathione Sepharose 4B Sales, Value and Gross Margin (2021-2026)
- 8.6.4 ZELLX Biochem Glutathione Sepharose 4B Product Portfolio
- 8.6.5 ZELLX Biochem Recent Developments
- 8.7 Thermo Fisher Scientific
- 8.7.1 Thermo Fisher Scientific Company Information
- 8.7.2 Thermo Fisher Scientific Business Overview
- 8.7.3 Thermo Fisher Scientific Glutathione Sepharose 4B Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Thermo Fisher Scientific Glutathione Sepharose 4B Product Portfolio
- 8.7.5 Thermo Fisher Scientific Recent Developments
- 8.8 Takara Bio
- 8.8.1 Takara Bio Company Information
- 8.8.2 Takara Bio Business Overview
- 8.8.3 Takara Bio Glutathione Sepharose 4B Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Takara Bio Glutathione Sepharose 4B Product Portfolio
- 8.8.5 Takara Bio Recent Developments
- 8.9 Sino Biological
- 8.9.1 Sino Biological Company Information
- 8.9.2 Sino Biological Business Overview
- 8.9.3 Sino Biological Glutathione Sepharose 4B Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Sino Biological Glutathione Sepharose 4B Product Portfolio
- 8.9.5 Sino Biological Recent Developments
- 8.10 Separopore®
- 8.10.1 Separopore® Company Information
- 8.10.2 Separopore® Business Overview
- 8.10.3 Separopore® Glutathione Sepharose 4B Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Separopore® Glutathione Sepharose 4B Product Portfolio
- 8.10.5 Separopore® Recent Developments
- 8.11 Merck
- 8.11.1 Merck Company Information
- 8.11.2 Merck Business Overview
- 8.11.3 Merck Glutathione Sepharose 4B Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Merck Glutathione Sepharose 4B Product Portfolio
- 8.11.5 Merck Recent Developments
- 8.12 MedChemExpress
- 8.12.1 MedChemExpress Company Information
- 8.12.2 MedChemExpress Business Overview
- 8.12.3 MedChemExpress Glutathione Sepharose 4B Sales, Value and Gross Margin (2021-2026)
- 8.12.4 MedChemExpress Glutathione Sepharose 4B Product Portfolio
- 8.12.5 MedChemExpress Recent Developments
- 8.13 GenScript
- 8.13.1 GenScript Company Information
- 8.13.2 GenScript Business Overview
- 8.13.3 GenScript Glutathione Sepharose 4B Sales, Value and Gross Margin (2021-2026)
- 8.13.4 GenScript Glutathione Sepharose 4B Product Portfolio
- 8.13.5 GenScript Recent Developments
- 8.14 Cytiva
- 8.14.1 Cytiva Company Information
- 8.14.2 Cytiva Business Overview
- 8.14.3 Cytiva Glutathione Sepharose 4B Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Cytiva Glutathione Sepharose 4B Product Portfolio
- 8.14.5 Cytiva Recent Developments
- 8.15 Cube Biotech
- 8.15.1 Cube Biotech Company Information
- 8.15.2 Cube Biotech Business Overview
- 8.15.3 Cube Biotech Glutathione Sepharose 4B Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Cube Biotech Glutathione Sepharose 4B Product Portfolio
- 8.15.5 Cube Biotech Recent Developments
- 8.16 Creative BioMart
- 8.16.1 Creative BioMart Company Information
- 8.16.2 Creative BioMart Business Overview
- 8.16.3 Creative BioMart Glutathione Sepharose 4B Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Creative BioMart Glutathione Sepharose 4B Product Portfolio
- 8.16.5 Creative BioMart Recent Developments
- 8.17 BioVision
- 8.17.1 BioVision Company Information
- 8.17.2 BioVision Business Overview
- 8.17.3 BioVision Glutathione Sepharose 4B Sales, Value and Gross Margin (2021-2026)
- 8.17.4 BioVision Glutathione Sepharose 4B Product Portfolio
- 8.17.5 BioVision Recent Developments
- 8.18 Bio-Rad Laboratories
- 8.18.1 Bio-Rad Laboratories Company Information
- 8.18.2 Bio-Rad Laboratories Business Overview
- 8.18.3 Bio-Rad Laboratories Glutathione Sepharose 4B Sales, Value and Gross Margin (2021-2026)
- 8.18.4 Bio-Rad Laboratories Glutathione Sepharose 4B Product Portfolio
- 8.18.5 Bio-Rad Laboratories Recent Developments
- 8.19 Abcam
- 8.19.1 Abcam Company Information
- 8.19.2 Abcam Business Overview
- 8.19.3 Abcam Glutathione Sepharose 4B Sales, Value and Gross Margin (2021-2026)
- 8.19.4 Abcam Glutathione Sepharose 4B Product Portfolio
- 8.19.5 Abcam Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Glutathione Sepharose 4B Value Chain Analysis
- 9.1.1 Glutathione Sepharose 4B Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Glutathione Sepharose 4B Sales Mode & Process
- 9.2 Glutathione Sepharose 4B Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Glutathione Sepharose 4B Distributors
- 9.2.3 Glutathione Sepharose 4B Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst